HULU - Available now on the streaming service, Vice Investigates “Anti-Vaxx Fever” explores the growing anti-vaccine movement. The documentary features in-depth looks at the varied work of professor Mark Roberts and of student Beth Hoffman (BCHS ’19 ’23). Each uses system science methods to investigate the dangers of this movement, generating compelling images that are powerful tools for communicating science to the public.
Mina Kabiri (HPM '17) is the associate director of global health economics and value demonstration at the Health Economics and Market Access division of Johnson and Johnson Medical Devices Companies. In her role, she leads the global efforst of developing health economic modeling tools for orthopedics, bio-surgery, and cardiovascular medical devices.
Ray Van Cleve (HPM '19) is working at the PRIME Center, a collaboration between Yale School of Medicine and The West Haven VA Hospital. He is working on the Pain and Opioids Consortium of Research (CORE) serving as the group's statistician and helping manage some of the group's day to day projects of the group.
Cassandra Leighton (HPM '19) is a health services solutions analyst at AmeriHealth Caritas. Headquartered in Philadelphia, AmeriHealth Caritas is a managed care organization, serving over 5.1 million Medicaid, Medicare, and Children's Health Insurance Program (CHIP) members across 11 states. In her role on the corporate analytics team, Leighton supports internal evaluation, participates in the new market entry process, and identifies new strateg...
Inmaculada Hernandez (HPM ’16) is assistant professor in the Pitt School of Pharmacy. She earned her PharmD degree and a master's in health economics in Spain and completed her PhD at Pitt Public Health in three years. She has earned multiple academic awards as she continues her career in the health services of pharmaceutical polices, culminating in being named one of Forbes magazine’s 30 Under 30 in Healthcare in 2019.
HEALIO - During a shortage, drug prices increase two times as quickly as they would have in the absence of a shortage, according to findings published in Annals of Internal Medicine. “Prescription drug shortages may result in substitution of less effective drugs, delays in necessary treatments, and omission of or reductions in doses,” INMACULADA HERNANDEZ (HPM '16) and colleagues wrote.
More Pitt Public Health News
POLITICO - The payment deal for Kymriah therapy drew internal HHS scrutiny and is the target of current congressional investigations of Swiss drug giant Novartis. The company's pivotal study of the drug's in children with acute lymphoblastic leukemia found that at one year, about one out of every three patients the government would be covering would get sick again, said INMACULADA HERNANDEZ (HPM '16).